Studies
Niclonex
Completed
Original Drug Treatment for Covid-19
MP-204
Completed
Topical Product for the Treatment of Viral Skin Infections
MP-303
Continuing
Topical Product for the Treatment of Nonmelanoma Skin Cancers
MP-4 Series
Continuing
Pain Treatment Platform NSAID Technology Platform (“NTP”)
Opix
Completed
A completely new MoA for severe pain
MP-732
Completed
